SRL
CDLX icon

Scientech Research LLC’s Cardlytics CDLX Stock Holding History

Scientech Research LLC’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,921
Closed -$33.6K – 509
2025
Q4 		$33.6K Buy
+2,921
New +$45.1K 0.02% 459

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Scientech Research LLC's CDLX Position: Q1 2026 in Review

Scientech Research LLC sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 2,921 shares — an estimated $33.6K sold.

Scientech Research LLC first reported a position in CDLX in Q4 2025 and held it in 1 quarter. The position peaked at $33.6K in Q4 2025. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Scientech Research LLC reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 2,921 Cardlytics shares in Q1 2026, an estimated $33.6K.
  • Scientech Research LLC first reported a position in Cardlytics in Q4 2025 and held it in 1 quarter.
  • Scientech Research LLC's Cardlytics position peaked at $33.6K in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.